|
Mar 20
|
Q4 2023 Corvus Pharmaceuticals Inc Earnings Call
|
|
Mar 19
|
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
|
|
Mar 13
|
Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2023 Financial Results on March 19, 2024
|
|
Mar 9
|
We Think Corvus Pharmaceuticals (NASDAQ:CRVS) Needs To Drive Business Growth Carefully
|
|
Dec 9
|
Corvus Pharmaceuticals Presents New Interim Soquelitinib Data from its Phase 1/1b T Cell Lymphoma Trial
|
|
Dec 7
|
Are Medical Stocks Lagging Corvus Pharmaceuticals (CRVS) This Year?
|
|
Aug 8
|
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results
|